Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POTASSIUM, MONOBASIC vs PRALSETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

POTASSIUM, MONOBASIC vs PRALSETINIB: Safety Overview

Metric POTASSIUM, MONOBASIC PRALSETINIB
Total FAERS Reports 149 1,419
Deaths Reported 38 226
Death Rate 25.5% 15.9%
Hospitalizations 40 431
Average Patient Age 56.1 yrs 61.9 yrs
% Female Patients 22.5% 56.6%
FDA Approval Date N/A Sep 4, 2020
Manufacturer Rising Pharma Holdings, Inc. Genentech, Inc.
Route ORAL ORAL
Marketing Status N/A Prescription